American Century Companies’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
AWG
CC
PA
SSC
VC
AC
American Century Companies's ANRO Position: Q2 2026 in Review
American Century Companies increased its Alto Neuroscience (ANRO) stake by 89% in Q2 2026, buying an estimated $292K and bringing the position to 26,820 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #2507.
American Century Companies first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.
- American Century Companies held 26,820 shares of Alto Neuroscience worth $708K as of Q2 2026.
- American Century Companies bought 12,634 Alto Neuroscience shares in Q2 2026, an estimated $292K.
- Alto Neuroscience made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2507 holding.
- American Century Companies first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
- 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.